STS Evermedia Corp.(fka SEVM)

[Chinga]

Cambodian Ventures Limited Reaches Definitive Agreement to Acquire Interest in a Biomedical Company Specializing in Human Avian Influenza Solutions
11/3/2005 4:14:21 PM
LOWELL, MA AND PHNOM PENH, CAMBODIA AND MONTREAL, Nov 03, 2005 (MARKET WIRE via COMTEX) -- Cambodian Ventures Limited ( CMBV ), announced today that it has reached a definitive agreement to acquire up to 25% of Montreal based Canadian Bio Med Systems Inc.

CBMS will focus on providing education, preventive and protective products, as well as anti-influenza medications.

Canadian Bio Med Systems (CBMS) is a company recently formed to provide solutions to the general public in dealing with the containment of the deadly avian influenza A virus (H5N1), also known as "Bird Flu," among humans.

In conjunction with developing a consistent source of Tamiflu for use in the treatment of H5N1, the company is pursuing the evaluation of a treatment of Avian Flu through the use of low dose Oral Interferon, which is available for sale in Cambodia, Laos and Vietnam. Low dose Oral Interferon is manufactured by Amarillo Biosciences, Inc. and distributed in South East Asia by Global Kinetics of Cambodia.

CBMS's goal is to provide education and products to prevent the spread of Avian Flu, protect individuals who live or travel through areas of risk, and to provide available treatment modalities that are available in various countries that are affected.

Among the founders of CBMS is Dr. George Tsoukas, M.D., Endocrinologist, Associate Professor, McGill University Health Centre, Montreal, Quebec. Dr. Tsoukas has extensive experience in medical education and has produced and directed a popular television program explaining medical conditions to the public. Dr. Tsoukas was chief examiner for the Quebec College of Endocrinologists. He obtained his medical degree at McGill University and received further training in internal medicine, cardiology, and endocrinology. He is a fellow in the Royal College of Physicians and Surgeons of Canada.

Canadian Bio Med Systems web site www.canadianbiomed.com

Safe Harbor Statement: The statements, other than the statements of historical facts may be deemed to contain forward-looking statements with respect to events, the occurrence of which involves risk and uncertainties, including, without limitation, demand and competition for the company's products and services, the availability to the company of adequate financing to support its anticipated activities, the ability of the company to generate cash flow from operations and the ability of the company to manage its operations.


CONTACT:
Cambodian Ventures Investor Relations
1-416-356-4737
www.cambodianventures.com


SOURCE: Cambodian Ventures Limited

http://www.cambodianventures.com